Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Sep 9, 2012
The sequencing of the human genome has opened incredible potential for personalizing treatment for many diseases. Dr. Keith Churchwell, executive director and chief medical officer for the Vanderbilt Heart and Vascular Institute, discusses the promise of discovery for improving how we identify patients at risk for heart disease, how we personalize treatment and how we even prevent the disease in the first place. The Promise of Discovery. Vanderbilt University Medical Center.